You have no items in your shopping cart.
You have no items in your shopping cart.

| Catalog Number | orb1983287 |
|---|---|
| Category | Small Molecules |
| Description | INY-03-041 trihydrochloride, a potent and highly selective PROTAC-based pan-AKT degrader, comprises Ipatasertib, an ATP-competitive AKT inhibitor, conjugated to Lenalidomide. It effectively inhibits AKT1, AKT2, and AKT3 with IC50 values of 2.0, 6.8, and 3.5 nM, respectively. |
| Target | PROTACs |
| MW | 907.8 |
| Formula | C44H59Cl4N7O5 |
| Storage | -20°C |
| Research Area | Pharmacology & Drug Discovery |
| Note | For research use only |
| Expiration Date | 12 months from date of receipt. |
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review(Recommended: An additional animal making an allowance for loss during the experiment)
(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)